Blood Coagulation Disorder clinical trials at UCLA

1 research study open to eligible people

VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease (VIVID)
open to eligible people ages 12-60
The VIVID study is structured in a master protocol format comprised of multiple parts that evaluate intravenous (IV) and subcutaneous (SC) VGA039 in healthy volunteers and subjects with von Willebrand Disease (VWD) and other bleeding disorders.
Los Angeles 5368361, California 5332921 and other locations

Last updated: August 19, 2025